In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Practice Guideline track on Stable Coronary Artery Disease

Guidelines into Practice

Chronic Ischaemic Heart Disease (IHD)
Cardiovascular Surgery

Contributor:  Special thanks to Rogério Teixeira and Lino Gonçalves from European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Based on the 2013 ESC guidelines on the management of stable coronary artery disease.

Webinar:  Current management of stable coronary artery disease. Diagnosis, medical treatment and options for revascularization Watch the recording.


Part 1 - Overview of the 2013 ESC guideline on the management of stable coronary artery disease  

 Session Presentation Title Slides Webcast
New 2013 ESC Guidelines on stable coronary artery disease
Stable coronary artery disease beyond flow-limiting stenoses.
Diagnosis and prognosis of stable coronary artery disease.    
Drugs in stable coronary artery disease     
From optimal medical therapy to revascularisation     
Take home message for practitioners Coronary artery disease update 2013    
FOCUS Imaging and intervention: Angina pectoris stable   Risk stratification in patient with stable angina. Imaging techniques and risk stratification. Insights from 2013 ESC Guidelines.    
Asymptomatic patient with stroke and cardiovascular risk factors. Do we need further cardiac evaluation of this high risk population?    


Part 2 - Topics in focus

Topic Presentation Title Slides Webcast

Perfusion or anatomy imaging. Do we need both?    
Nuclear perfusion imaging and cardiac computed tomography    
Combined wall motion and myocardial perfusion imaging by cardiac magnetic resonance.    
Coronary Angiography Assessing fractional flow reserve in patients with microvascular dysfunction    
Proven ischaemia and non-obstructive coronary artery disease    
Assessing the microcirculation in dysfunctional myocardium after myocardial infarction.    
Use of coronary angiography in patients with stable ischaemic heart disease    
  Meet the expert: Non-intervention versus intervention in stable angina 
Ischaemia as the gatekeeper.      
The cathlab identifies and solves the problem.      
Non-intervention versus intervention in stable angina - Take home message & what do the guidelines say?      
Fractional flow reserve-guided percutaneous coronary intervention versus medical therapy for stable coronary disease: a definitive trial?      
Left main stem stenosis: insights from SYNTAX to EXCEL.       
5-year follow-up from SYNTAX trial: the messages.      
Certainties and controversies      
ASCERT: comparative efficacy or not in real world three-vessel coronary artery disease?      
No more FREEDOM of choice.      
SYNTAX - making simple sense out of the complexities of multivessel coronary artery disease.      
Fractional flow reserve and all that FAME: what's significant in coronary artery disease?     
Revascularisation options in diabetic patients: updates from FREEDOM.      
Comparative effectiveness of revascularisation strategies.      
Risk scores: should I bother?       
Completeness of revascularisation: in whom does it matter?      
FREEDOM and the future.      
Putting it all together - past, present and future.      
Novel and emerging therapies for managing the patient with advanced coronary artery disease.     
Myocardial revascularisation in patients with diabetes - coronary artery bypass grafting or percutaneous coronary intervention?      
 Miscellaneous Management of cardiovascular disease in diabetes      
Multifocal atherosclerosis in patients with coronary artery disease
Should we look for it and how?      
Should they be treated differently?      
An algorithm for invasive treatment in a polyvascular patient.      
Positron emission tomography/computed tomography and molecular imaging for multifocal atherosclerosis: luxury or necessity?